Bone Cancer Clinical Trials 2024

Bone Cancer Clinical Trials 2024

Bone Cancer research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in bone cancer clinical trials today.

Trials for Chondrosarcoma Patients

Trials for Soft Tissue Sarcoma Patients

Trials for Metastatic Patients

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to bone cancer

What are the top hospitals conducting bone cancer research?

When it comes to the battle against bone cancer, several hospitals have emerged as leaders in conducting clinical trials that pave the way for innovative treatments. In sunny Miami, Nicklaus Children's Hospital is making strides with two active bone cancer trials and a total of two recorded trials dedicated to this challenging condition. The hospital initiated its first bone cancer trial in 2014—an important milestone in their ongoing commitment to improving patient outcomes. Meanwhile, M D Anderson Cancer Center in Houston stands alongside Nicklaus Children's Hospital with an equal number of active and all-time bone cancer trials, demonstrating their dedication to finding breakthroughs in this field since 2014.

Heading over to Colorado Springs, Penrose-Saint Francis Healthcare and Rocky Mountain Cancer Centers-Penrose are leading the charge against bone cancer by each conducting two active clinical trials while having completed a pair of earlier investigations focused on this complex disease. Both hospitals made significant contributions starting from 2014 when they embarked on their respective journeys towards advancing treatments for patients battling bone cancer.

Further north in Denver, Porter Adventist Hospital also joins the ranks with two ongoing clinical trials dedicated solely to combating bone cancer. Their commitment started back in 2014—pioneering efforts that continue to impact countless lives affected by this devastating illness.

These hospitals represent beacons of hope for those facing the challenges posed by bone cancer. Through relentless research efforts and groundbreaking clinical studies, these institutions emphasize that no stone should be left unturned when fighting such a formidable opponent as they strive toward developing more effective treatments and ultimately achieving brighter futures for patients worldwide.

Which are the best cities for bone cancer clinical trials?

In the realm of bone cancer clinical trials, several cities emerge as key players in research and treatment. Des Moines, Iowa takes the lead with 10 ongoing trials investigating diverse approaches such as Control arm, Stereotactic Radiosurgery, and 9-ING-41. Denver, Colorado follows closely with 9 active trials exploring interventions like Control arm and Stereotactic Radiosurgery. Springfield, Illinois also showcases its commitment to advancing bone cancer treatments through 6 studies focusing on Stereotactic Radiosurgery and Control arm among others. Meanwhile, Chicago, Illinois and Colorado Springs, Colorado contribute to the field with their respective investigations into promising methods like Stereotactic Radiosurgery and Control arm. These cities offer valuable opportunities for individuals seeking participation in cutting-edge bone cancer clinical trials that have the potential to shape future treatment options positively.

Which are the top treatments for bone cancer being explored in clinical trials?

In the world of bone cancer research, several treatments are currently being explored in clinical trials. One standout is 18F-sodium fluoride, with one active trial and a total of one trial dedicated to bone cancer since its listing in 2008. Another contender is tranexamic acid, also undergoing one active trial and two all-time bone cancer trials after being introduced in 2013. Lastly, there's 9-ING-41—an up-and-comer—currently involved in one ongoing trial for bone cancer since its debut in 2019. These innovative treatments hold promise for improving the lives of patients battling this challenging disease.

What are the most recent clinical trials for bone cancer?

In the realm of bone cancer research, recent clinical trials have offered promising prospects for improved treatments. One notable study is UB_TT170, a Phase 1 trial that became available on 5/20/2022. Additionally, Dose Level 1, another Phase 1 trial introduced on 4/5/2022 demonstrates potential benefits for patients with bone cancer. Moreover, Tranexamic Acid has undergone a Phase 3 clinical trial which commenced on 1/29/2021 and brings hope in advancing treatment options further. These ongoing investigations underscore the dedication to finding innovative solutions to combat this challenging disease and offer renewed optimism for those affected by bone cancer.

What bone cancer clinical trials were recently completed?

A notable clinical trial in the field of bone cancer research has recently concluded, marking a significant step forward in understanding and treating this challenging disease. In November 2017, Amgen successfully completed a trial investigating Denosumab (Cohort A) as a potential therapy for bone cancer. This study contributes valuable insights into the efficacy and safety of Denosumab in addressing the unique challenges posed by bone cancers. The completion of this trial represents an important milestone in ongoing efforts to improve treatments and outcomes for patients dealing with these complex malignancies.